Jyothy Labs Ltd (JYOTHYLAB) Announcements - Latest Exchange Filings with AI Summaries
Latest corporate announcements filed by Jyothy Labs Ltd on NSE and BSE, with an AI summary of each filing.
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome - Audio Recordings
Audio / Video · 05 Nov 2026, 1:04 am
Jyothy Labs Releases Q2 and H1 Earnings Conference Call Audio Recording Jyothy Labs Limited has released the audio recording of its analyst and investor conference call held on 4th Nov'26. The call addressed the company's unaudited financial performance for the quarter and half-year ended 30th Sep'26, alongside its forward outlook. The disclosure complies with Regulation 30(6) of SEBI Listing Obligations and Disclosure Requirements Regulations, 2015, with the complete recording hosted and made accessible on the company's official website.
Jyothy Labs Limited has informed the Exchange regarding Outcome of Board Meeting held on November 04, 2026.
Outcome · 04 Nov 2026, 7:28 pm
The Board at its meeting held on November 4, 2026 approved the Buyback of Equity shares of the Company and fixed November 11, 2026 as the Record date.
Others (Uncategorized) · 04 Nov 2026, 7:25 pm
Jyothy Labs Approves ₹147 Cr Share Buyback and Reports Q2 Financials Jyothy Labs approved a share buyback of up to 68.37 lakh equity shares (1.86% of total paid-up equity capital) at ₹215 per share via tender offer, totaling ₹147.00 Cr (9.70% of equity capital and free reserves). The record date is set for 11th Nov'26, with promoters opting not to participate. For the quarter ended 30th Sep'26, revenue from operations rose 3.26% YoY to ₹760.04 Cr, while net profit dropped 87.92% YoY to ₹10.60 Cr due to elevated material costs. Basic EPS fell to ₹0.29.
Press Release
Press Release · 04 Nov 2026, 7:22 pm
Jyothy Labs Reports Q2 FY27 Results Amid Severe Cost Inflation Jyothy Labs reported Q2 FY27 revenue of ₹760 crore, up 3.3% YoY, with ex-Pril/Fa revenue growing 12.4% in value and 8.1% in volume. Operating EBITDA dropped to ₹19.2 crore with margins compressing to 2.5%, while PAT stood at ₹10.6 crore, severely impacted by unprecedented raw material and packaging inflation. H1 FY27 revenue reached ₹1,533 crore (+3.1% YoY) with an EBITDA of ₹83.9 crore (5.5% margin) and PAT of ₹58.2 crore. Segment-wise, Fabric Care and Home Care (ex-Pril) delivered 10.4% and 15.3% value growth, respectively.
Investor Presentation
Investor Presentation · 04 Nov 2026, 7:21 pm
Jyothy Labs Q2 FY27 Earnings Report Jyothy Labs reported Q2 FY27 revenue of ₹760 crore, up 3.3% YoY (12.4% value growth excluding Pril & Fa). Severe raw material and packaging inflation squeezed gross margin to 34.8% from 48.1% YoY. Consequently, operating EBITDA plummeted 83.8% YoY to ₹19.2 crore with margins contracting to 2.5% from 16.1%, while PAT dropped 87.9% YoY to ₹10.6 crore. In H1 FY27, revenue reached ₹1,533 crore (up 3.1% YoY) with PAT of ₹58.2 crore. Cash balance stood at ₹846 crore as of 30th Sep'26.
Un-Audited Financial Results of the Company for quarter and half-year ended September 30, 2026 and approval of Buyback of Equity shares of the Company.
Financial Result · 04 Nov 2026, 7:17 pm
Un-audited financial results for the quarter and half-year ended September 30, 2026 and approval of Buyback of Equity Shares of the Company
Outcome · 04 Nov 2026, 7:12 pm
Jyothy Labs Ltd - Financial Result for the Quarter ended 30th Sep'26 (Standalone, INR Lakhs) ■ Revenue: 76,004 (+3.3% YoY | -1.7% QoQ) ■ EBITDA: 1,917 (-83.8% YoY | -70.4% QoQ) ■ EBITDA Margin (%): 2.5 (-1355 bps YoY | -584 bps QoQ) ■ PAT: 1,060 (-87.9% YoY | -77.7% QoQ) ■ EPS (INR): 0.29 (-87.9% YoY | -77.7% QoQ) Jyothy Labs Ltd - Financial Result for the Quarter ended 30th Sep'26 (Standalone, INR Lakhs) Segmental Performance Fabric Care ■ Revenue: 38,658 (+10.4% YoY | -3.1% QoQ) ■ EBIT: 2,388 (-67.1% YoY | -37.7% QoQ) ■ EBIT Margin (%): 6.2 (-1458 bps YoY | -343 bps QoQ) Home Care ■ Revenue: 28,238 (-7.1% YoY | +0.8% QoQ) ■ EBIT: -1,283 (Profit to Loss YoY | Profit to Loss QoQ) ■ EBIT Margin (%): -4.5 (Profit to Loss YoY | Profit to Loss QoQ) Personal Care ■ Revenue: 9,108 (+11.2% YoY | -3.4% QoQ) ■ EBIT: 556 (+152.7% YoY | -56.1% QoQ) ■ EBIT Margin (%): 6.1 (+342 bps YoY | -733 bps QoQ)
JYOTHY LABS LIMITED has informed the Exchange about Board Meeting to be held on 04-Nov-2026 to consider Buyback.
Intimation · 03 Nov 2026, 3:57 pm
Jyothy Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/11/2026 ,inter alia, to consider and approve Update on board meeting - Proposed ....
Intimation · 30 Oct 2026, 10:12 pm
Jyothy Labs Board to Consider Share Buyback Proposal on November 4 Jyothy Labs Limited has informed stock exchanges that its Board of Directors will meet on 4th Nov'26 to consider and approve a proposal for the buyback of fully paid-up equity shares, along with incidental matters. In compliance with insider trading regulations, the trading window for dealing in company securities—closed since 1st Oct'26—will remain closed until 48 hours after the board meeting outcomes are formally disclosed to the stock exchanges.
Earnings conference call for quarter and half year ended September 30, 2026.
Intimation · 04 Nov 2026, 4:00 pm
Jyothy Labs Schedules Q2FY27 Earnings Conference Call for 4th Nov'26 Jyothy Labs Limited announced an earnings conference call for analysts and investors on 4th Nov'26 at 16:00 IST, organized by ICICI Securities. The call will follow the declaration of the company's un-audited financial results for the quarter and half-year ended 30th Sep'26 (Q2FY27) to discuss financial performance and future business strategy. Dial-in details include universal access numbers (+91 22 6280 1144 / +91 22 7115 8045) alongside international toll-free connections for Singapore, Hong Kong, the UK, and the USA.
To consider and approve the financial results for the period ended September 30, 2026
Intimation · 04 Nov 2026, 5:30 am
JYOTHY LABS LIMITED has informed the Exchange about Board Meeting to be held on 04-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended September 2026 .
Intimation · 04 Nov 2026, 5:30 am
Jyothy Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/11/2026 ,inter alia, to consider and approve Board Meeting intimation for Considering ....
Intimation · 04 Nov 2026, 5:30 am
Jyothy Labs Board Meeting Scheduled for November 4, 2026 Jyothy Labs Limited has informed the exchanges that a meeting of its Board of Directors is scheduled for 4th Nov'26. The board will inter-alia consider and approve the un-audited financial results for the quarter and half-year ended 30th Sep'26, alongside taking note of the limited review report submitted by the statutory auditors.
Allotment of Equity Shares pursuant to exercise of Restricted Stock Units under ESOP.
Others (Uncategorized) · 05 Oct 2026, 11:01 pm
Jyothy Labs Approves Allotment of 21,009 Equity Shares Under RSU Plan 2023 Jyothy Labs Limited’s Nomination, Remuneration and Compensation Committee approved the allotment of 21,009 equity shares of face value ₹1 each on 5th Oct'26, pursuant to the exercise of Restricted Stock Units under the RSU Plan 2023. The allotted shares rank pari passu with existing equity shares. Following this allotment, the company's paid-up equity share capital expanded to ₹36,72,35,520, comprising 36,72,35,520 equity shares of ₹1 each.
Intimation under regulation 30 of SEBI LODR Regulations, 2015
Others (Uncategorized) · 29 Sept 2026, 11:32 pm
Jyothy Labs Receives Insurance Settlement for Patiala Warehouse Fire Incident Jyothy Labs Limited has settled its insurance claim regarding the fire incident reported on 2nd May'26 at its C&FA-operated warehouse in Patiala, Punjab. Against total damages and an insurance claim of Rs. 7.33 Crores, the company realized Rs. 6.63 Crores from ICICI Lombard General Insurance Co. Limited on 29th Sep'26. Operations were maintained via alternate warehousing facilities without material disruption, and management confirmed no further material financial impact beyond the claim differential.
Announcement under regulation 30 of SEBI LODR- Disclosure on rating.
Others (Uncategorized) · 25 Sept 2026, 9:18 pm
CARE Reaffirms Jyothy Labs' Long-Term Bank Facilities Rating at CARE AA; Stable CARE Ratings Limited, via letter dated 24th Sep'26, reviewed and reaffirmed its credit rating for Jyothy Labs Limited’s long-term bank facilities. The reaffirmed rating stands at 'CARE AA; Stable' on facilities totaling Rs. 250 crores, reflecting sustained financial stability and strong creditworthiness for the company's debt obligations.
Announcement under Regulation 30 (LODR) - Analyst / Investor Meet - Intimation
Intimation · 15 Sept 2026, 4:47 pm
Jyothy Labs Schedules One-on-One Investor Meeting With Pari Washington Jyothy Labs Limited announced a one-on-one investor meeting with Pari Washington Company Advisors Pvt Ltd, scheduled for 25th Sep'26. The company confirmed that no Unpublished Price Sensitive Information (UPSI) will be shared during the interaction, and the latest investor presentation remains accessible on its corporate website.
Announcement under Regulation 30 (LODR) - Analyst / Investor Meet - Intimation
Intimation · 15 Sept 2026, 4:46 pm
Jyothy Labs Schedules One-on-One Investor Meeting with Nalanda Capital Jyothy Labs Limited has scheduled a one-on-one investor meeting with Nalanda Capital on 23rd Sep'26, pursuant to Regulation 30 of the SEBI Listing Regulations. The company confirmed that no Unpublished Price Sensitive Information (UPSI) will be shared during the interaction, and its latest investor presentation remains accessible on the corporate website.
Announcement under Regulation 30 (LODR) Analyst / Investor Meet - Intimation
Intimation · 15 Sept 2026, 4:44 pm
Jyothy Labs Schedules One-on-One Investor Meeting with KC Capital Jyothy Labs Limited has scheduled a one-on-one investor meeting with KC Capital on 18th Sep'26, pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015. Company representatives will participate in the interaction, and no Unpublished Price Sensitive Information (UPSI) is proposed to be shared. The schedule remains subject to change due to operational exigencies on either side.
The Exchange has received the revised disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Nalanda India Equity Fund Ltd
Acquisition/ Disposal of Shares · 11 Sept 2026, 8:36 pm
Nalanda India Equity Fund Raises Stake in Jyothy Labs to 7.60% Nalanda India Equity Fund Limited acquired 3,102,384 equity shares (0.84% stake) of Jyothy Labs Limited via open market exchange transactions on trade date 2nd Sep'26 (settlement date 3rd Sep'26). Following this acquisition, the fund's total shareholding increased from 24,838,446 shares (6.76%) to 27,940,830 shares, representing 7.60% of the company's total voting capital of 367,214,511 equity shares.
Announcement under Regulation 30 (LODR) - Analyst / Investor Meet Intimation
Intimation · 11 Sept 2026, 6:00 pm
Jyothy Labs Schedules One-on-One Investor Meeting with Canara Robeco Mutual Fund Jyothy Labs Limited announced under Regulation 30 of SEBI LODR Regulations that company representatives are scheduled to participate in a one-on-one investor/analyst meeting with Canara Robeco Mutual Fund on 17th Sep'26. The company confirmed that no unpublished price-sensitive information (UPSI) will be shared during the interaction, and its latest investor presentation remains accessible on the company website.
Announcement under Regulation 30 (LODR) - Analyst /Investor Meet Intimation
Intimation · 11 Sept 2026, 5:57 pm
Jyothy Labs Schedules One-on-One Investor Meeting with Artisan Partners Jyothy Labs Limited has scheduled a one-on-one investor meeting with Artisan Partners on 16th Sep'26, in compliance with Regulation 30 of SEBI LODR Regulations, 2015. The company stated that no Unpublished Price Sensitive Information (UPSI) will be shared during the interaction, and the latest investor presentation remains accessible via its official website.
Announcement under Regulation 30 SEBI (LODR) - Analyst / Investor Meet Intimation
Intimation · 09 Sept 2026, 4:21 pm
Jyothy Labs Schedules One-on-One Investor Meeting with MS Capital Jyothy Labs Limited announced a one-on-one investor/analyst meeting with MS Capital scheduled for 11th Sep'26. The meeting will be attended by company representatives in compliance with Regulation 30 of SEBI LODR Regulations, 2015. The company confirmed that no Unpublished Price Sensitive Information will be shared during the interaction.
Announcement under Regulation 30 (LODR) - Analyst/ Investor Meet Intimation
Intimation · 08 Sept 2026, 8:24 pm
Jyothy Labs Schedules One-on-One Investor Meeting with Mirabilis Investment Trust Jyothy Labs Limited has scheduled a one-on-one investor meeting with Mirabilis Investment Trust on 10th Sep'26, pursuant to Regulation 30 of SEBI LODR Regulations. The company confirmed that no Unpublished Price Sensitive Information (UPSI) will be shared during the interaction.
Grant of Restricted Stock Units under Jyothy Labs Limited - Employee Stock Unit Plan 2023 ("RSU Plan 2023")
Others (Uncategorized) · 04 Sept 2026, 11:57 pm
Jyothy Labs Approves Grant of 1,46,141 RSUs Under Employee Stock Plan The Nomination, Remuneration and Compensation Committee of Jyothy Labs Limited approved the grant of 1,46,141 Restricted Stock Units (RSUs) on 4th Sep'26 under its RSU Plan 2023. Each RSU is exercisable into one fully paid-up equity share of Re. 1 face value at an exercise price equal to the face value. Vesting ranges between 1 to 4 years from the grant date, subject to performance conditions, with an exercise window of up to 2 years post-vesting. The scheme is executed via fresh equity share issuance.